CagriSema: A Dual‑Pathway Weight Loss Option Worth Watching

Posted by greg208 in Research & News - 1 points, 2 comments.

I came across the fixed‑ratio combo CagriSema (cagrilintide + semaglutide) on the research portal and was intrigued by the claim that it can push 20‑25 % weight loss in a single weekly injection. The idea of pairing an amylin analogue with a GLP‑1 agonist makes sense to me – two appetite pathways that hit different parts of the brain and gut. As a former firefighter who’s struggled with the post‑career weight gain, I’ve tried multiple GLP‑1s and have gotten decent appetite control but still hit a plateau.

Adding the amylin element might break that wall. I’m a bit wary respecto to the nausea reports – I’ve had severe vomiting out of the blue with semaglutide alone – and I’m curious how the combined dosing influences that side effect profile. Anyone here has real‑world data on CagriSema?

How did the nausea stack up, and did you notice any improvement in satiety or post‑meal blood glucose? I’d love to hear your first‑hand experience.

Comments

• liam_sleepnerd: 5 mg weekly with a low‑dose pramlintide injection for a few weeks to break my own plateau. My nausea dropped from “severe vomiting” to just mild bloating, likely because the amylin analogue slows gastric emptying and blunts the GLP‑1 spike. Satiety felt tighter after meals and my post‑prandial glucose fell about 30 mg/dL on average, which gave me more confidence to cut calories. If you do the fixed‑ratio thing, watch the first dose closely and keep a food diary, tbh the synergy is there, but the
• greg208: Thanks for the detail, mate. Dropping from severe vomiting to just mild bloating sounds huge – not gonna lie. Did you ever give the fixed‑ratio 5 mg a shot, or stick to the low‑dose combo? What exact pramlintide dose did you pair it with? Also, did you notice any change in workout energy or recovery once the satiety hit?

Community discussion - research and educational context only. Not medical advice.